RLS AND SOFIE ENTER STRATEGIC PARTNERSHIP FOR DISTRIBUTION OF NUCLEAR MEDICINE DOSES FOR PATIENTS
SOFIE to Manufacture Batches, RLS to Compound and Distribute to SOFIE Customers, Improving Continuum of Care for Patients
Read MoreSOFIE to Manufacture Batches, RLS to Compound and Distribute to SOFIE Customers, Improving Continuum of Care for Patients
Read MoreNew Appointment Marks Latest in RLS’s Commitment to Best-in-Class Regulation as Radiopharmacy Network Continues to Scale for Long-Term Growth
Read MoreMarks Latest Step in RLS Expansion into Oncology & Work to Create an Unbroken Chain of Patient Care from Clinical Trial to Commercial Supply
Read MoreLAKE ZURICH, IL., June 5, 2023 /PRNewswire/ — RLS (USA), Inc. (Radioisotope Life Sciences), the third-largest nuclear medicine pharmacy network in the US, has been awarded a national group purchasing agreement for the distribution of Radiopharmaceutical Products with Premier, Inc, a leading healthcare improvement company headquartered in Charlotte, North Carolina. […]
Read MoreExpands RLS Capabilities and Offerings across the US, Begins to Establish Commercial Footprint for Evergreen
Read MorePartnership is Latest in Series of RLS Efforts to Expand Industry-Leading CDMO Business and Clinical Trial Capability with Radiopharmaceutical Partners Across U.S.
Read MoreBankson’s Appointment Marks the Latest in Recent Slate of Executive Hires to Position RLS for Long-Term, Sustainable Growth and Success.
Read More